Satu Mustjoki#

Membership Number:6997
Membership type:ORDINARY
Section:CELL & DEVELOPMENTAL BIOLOGY
Affiliated section(s):CLINICAL & VETERINARY SCIENCE
Elected:2024
Main Country of Residence:FINLAND
Homepage(s):https://www.helsinki.fi/hematology
ORCID:0000-0002-0816-8241
Twitter:@hruh_research


Present and Previous Positions
  • 2019 Director of Translational Immunology Research Program, Faculty of Medicine, University of Helsinki (UH), Finland
  • 2018 Head of department, Helsinki University Hospital (HUS) Comprehensive Cancer Center, Helsinki Finland.
  • 2017 Professor of Translational Hematology (100%), UH, Finland.
  • 2015 - 2017 Research professor for the Finnish Cancer Institute
  • 2015 - 2017 Deputy professor of Clinical Chemistry and Hematology (35% position), UH, Finland
  • 2012 - 2015 Specialist doctor (5% position), HUS Comprehensive Cancer Center, Helsinki Finland
  • 2010 - 2014 Senior Research fellow (Academy of Finland), HUS, Helsinki, Finland
  • 2008 - 2010 Academy Clinical Researcher, HUS, Helsinki, Finland,
  • 2006 - 2006 Clinical lecturer, Dept. of Clinical Chemistry, University of Helsinki, Finland (6 months)
  • 2002 - 2006 Resident in Clinical Chemistry, Laboratory of Hematology, HUS, Helsinki, Finland
  • Career breaks: 2 children born in 2002 and 2004; Clinical specialization 2002 - 2008

Fields of Scholarship
  • Natural killer cells
  • Translational hematology
  • Somatic mutations
  • Personalized medicine
  • Autoimmune diseases
  • Cancer immunology
  • Immunological biomarkers discovery
  • Translational immunology
  • T cells

Honours and Awards
  • 2023 - 2025 Nomination for the Helsinki Institute of Life Science (HiLife) Fellow group
  • 2020 City of Helsinki Science award
  • 2017 - 2020 Nomination for the Helsinki Institute of Life Science (HiLife) Fellow group
  • 2019 ERC Proof-of-Concept awardee
  • 2018 Biomedicum Helsinki award
  • 2015 ERC Consolidator grant awardee
  • 2014 Instrumentarium Science foundation fellow award
  • 2012 One of the 7 research groups of the P-MOLMED (personalized molecular medicine) consortium which was ranked the number 1 research network in the University of Helsinki evaluation in the category of society impact
  • 2010 - 2015 Academy of Finland Senior research fellowship
  • 2008 - 2010 Academy of Finland Clinical researcher fellowship
  • 2001 PhD thesis (Urokinase, Urokinase Receptor, and ICAMs in Human Leukemia) accepted with distinction

Imprint Privacy policy « This page (revision-6) was last changed on Saturday, 29. June 2024, 22:32 by System
  • operated by